The optimal length of ‘coasting protocol’ in women at risk of ovarian hyperstimulation syndrome undergoingin vitrofertilization
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis in Human Fertility
- Vol. 9 (3), 175-180
- https://doi.org/10.1080/14647270600787575
Abstract
Ovarian hyperstimulation syndrome (OHSS) is a serious and potentially life-threatening complication following ovarian stimulation for in vitro fertilization (IVF). Coasting is the practice whereby the gonadotrophins are withheld and the administration of human chorionic gonadotrophin (hCG) is delayed until serum oestradiol (E2) has decreased to what is considered to be a safe level, to prevent the onset of OHSS. This study aimed to assess the length of coasting on the reproductive outcome in women at risk of developing OHSS. Coasting was undertaken when the serum E2 concentrations were ≥17000 pmol/L but 2 measurements were performed and hCG was administered when hormone levels decreased to P < 0.05) and decreased implantation rate (P < 0.05) compared to those coasted for 1 – 3 days. Pregnancy rate/embryo transfer and live birth rate did not differ between groups. In conclusion, coasting appears to decrease the risk of OHSS without compromising the IVF cycle pregnancy outcome. Prolonged coasting is, however, associated with reduced implantation rates, perhaps due to the deleterious effects on the endometrium rather than the oocytes.Keywords
This publication has 30 references indexed in Scilit:
- Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndromeHuman Reproduction, 2005
- Coasting acts through downregulation of VEGF gene expression and protein secretionHuman Reproduction, 2004
- Administration of Moderate and High Doses of Gonadotropins to Female Rats Increases Ovarian Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor-2 Expression that Is Associated to Vascular Hyperpermeability1Biology of Reproduction, 2003
- Coasting--what is the best formula?Human Reproduction, 2003
- Preventive attitude of physicians to avoid OHSS in IVF patientsHuman Reproduction, 2001
- Human Recombinant Luteinizing Hormone Is as Effective as, But Safer Than, Urinary Human Chorionic Gonadotropin in Inducing Final Follicular Maturation and Ovulation in in Vitro Fertilization Procedures: Results of a Multicenter Double-Blind StudyJournal of Clinical Endocrinology & Metabolism, 2001
- Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized studyHuman Reproduction, 1999
- Withholding gonadotropins (“coasting”) to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization–embryo transfer cyclesFertility and Sterility, 1999
- Ovarian Hyperstimulation SyndromeObstetrical & Gynecological Survey, 1998
- Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndromeThe Lancet, 1994